Arginine

Arginine

SCHEMBL1551248

CC(C)C[C@H](N)C(=O)O.CC[C@H](C)[C@H](N)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRCP P42785 2/20 0.35
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
NPY4R P50391 6/20 0.32
NPY1R P25929 5/20 0.32
NPY2R P49146 4/20 0.32
NPY5R Q15761 4/20 0.32
SLC7A5 Q01650 1/20 0.32
REN P00797 1/20 0.32
NOS2 P35228 2/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
DPP7 Q9UHL4 1/20 0.31
KEAP1 Q14145 1/20 0.31
OTC P00480 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL14841994 0.95 PRCP (0.38) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL23248653 0.95 PRCP (0.38) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL11905093 0.95 PRCP (0.38) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL25168271 0.93 PRCP (0.36) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL11905292 0.93 PRCP (0.35) PRCPNPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL28419523 0.93 PRCP (0.38) PRCPNPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL1697257 0.93 PRCP (0.38) PRCPNPY4RNPY1RNPY2RNPY5R
Arginine SCHEMBL2501111 0.92 PRCP (0.36) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL17982370 0.92 PRCP (0.36) PRCPMAPK8MAPK9MAPK10NOS2
Arginine SCHEMBL29157307 0.92 PRCP (0.35) PRCPNPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10350268-B2 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin A1M PHARMA AB (SE) 2019-07-16 US disclosed
EP-2638915-B1 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin A1M PHARMA AB (SE) 2016-10-19 EP disclosed
EP-2313106-B1 MEDICAL USE OF THE RADICAL SCAVENGER AND ANTIOXIDANT ALPHA-1-MICROGLOBULIN A1M PHARMA AB (SE) 2016-03-30 EP disclosed
EP-2638915-A1 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin A1M Pharma AB (SE) 2013-09-18 EP disclosed
US-20110190208-A1 MEDICAL USE OF THE RADICAL SCAVENGER AND ANTIOXIDANT ALPHA-1-MICROGLOBULIN Guard Therapeutics International AB (SE) 2011-08-04 US disclosed
EP-2313106-A2 MEDICAL USE OF THE RADICAL SCAVENGER AND ANTIOXIDANT ALPHA-1-MICROGLOBULIN Akerström, Bo (SE) 2011-04-27 EP disclosed
WO-2010006809-A2 MEDICAL USE OF THE RADICAL SCAVENGER AND ANTIOXIDANT ALPHA-1-MICROGLOBULIN AKERSTROEM BO (SE) 2010-01-21 WO disclosed